GetTopicDetailResponse(id=0a4e9223ee3, topicName=貝達喹啉, introduction=貝達喹啉, content=null, image=null, comments=1, allHits=1519, url=https://h5.medsci.cn/topic?id=92237, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=52711, tagList=[TagDto(tagId=52711, tagName=貝達喹啉)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2269302, encodeId=d4d6226930216, content=<a href='/topic/show?id=0e083162386' target=_blank style='color:#2F92EE;'>#分子標志物#</a> <a href='/topic/show?id=6e9f103104b9' target=_blank style='color:#2F92EE;'>#麻風(fēng)病#</a> <a href='/topic/show?id=acc54344461' target=_blank style='color:#2F92EE;'>#多藥聯(lián)合治療#</a> <a href='/topic/show?id=0a4e9223ee3' target=_blank style='color:#2F92EE;'>#貝達喹啉#</a>, objectTitle=NEJM：貝達喹啉（Bedaquiline）治療麻風(fēng)病的最新臨床研究進展, objectType=article, longId=882308, objectId=fc21882308ff, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20250605/a68c3260b4aa4f2bb6471e5dbc6fb4db-k4ENQRQyNFbh.jpg, objectUrl=/article/show_article.do?id=fc21882308ff, replyNumber=0, likeNumber=30, createdTime=2025-06-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亞, moduleDTOList=[ModuleDTO(moduleId=fc21882308ff, moduleTitle=NEJM：貝達喹啉（Bedaquiline）治療麻風(fēng)病的最新臨床研究進展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fc21882308ff)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2250480, encodeId=a8eb225048014, content=<a href='/topic/show?id=391de865327' target=_blank style='color:#2F92EE;'>#結(jié)核病#</a> <a href='/topic/show?id=2f363232442' target=_blank style='color:#2F92EE;'>#利福平#</a> <a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a> <a href='/topic/show?id=6b1b8e9908a' target=_blank style='color:#2F92EE;'>#莫西沙星#</a> <a href='/topic/show?id=0a4e9223ee3' target=_blank style='color:#2F92EE;'>#貝達喹啉#</a> <a href='/topic/show?id=59ed5084328' target=_blank style='color:#2F92EE;'>#德拉馬尼#</a>, objectTitle=NEJM：利福平耐藥、氟喹諾酮敏感結(jié)核病的口服治療方案（endTB 試驗）, objectType=article, longId=861986, objectId=a1d1861986b5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250203/1738653528901_4754896.jpg, objectUrl=/article/show_article.do?id=a1d1861986b5, replyNumber=1, likeNumber=39, createdTime=2025-02-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=a1d1861986b5, moduleTitle=NEJM：利福平耐藥、氟喹諾酮敏感結(jié)核病的口服治療方案（endTB 試驗）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a1d1861986b5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=969503, encodeId=1c919695032c, content=<a href='/topic/show?id=0a4e9223ee3' target=_blank style='color:#2F92EE;'>#貝達喹啉#</a>這個本來是多藥耐藥結(jié)核病的藥物。, objectTitle=Cell Death Differ：貝達喹啉Bedaquiline靶向ATP5F1C預(yù)防癌細胞轉(zhuǎn)移, objectType=article, longId=212007, objectId=a92821200ef4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021528/1622213469213_2467676.PNG, objectUrl=/article/show_article.do?id=a92821200ef4, replyNumber=0, likeNumber=109, createdTime=2021-05-29, rootId=0, userName=小小醫(yī)者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a92821200ef4, moduleTitle=Cell Death Differ：貝達喹啉Bedaquiline靶向ATP5F1C預(yù)防癌細胞轉(zhuǎn)移, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a92821200ef4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
